Vous avez cherché: aspergillus (Slovaque - Anglais)

aspergillus
aspergillus

aspergillus nidulans
aspergillus nidulans

fermentačný produkt aspergillus oryzae
fermentation product of aspergillus oryzae

aspergillus flavus: 0,5 mg/l
aspergillus flavus: 0.5 mg/l

ŠpecifikÁcie chitÍnglukÁnu z aspergillus niger
specifications of chitin-glucan from aspergillus niger mycelium

kataláza získaná z aspergillus niger,
catalase derived from aspergillus niger,

chitozan odvodený z huby aspergillus niger,
chitosan derived from aspergillus niger,

mikroorganizmom aspergillus niger (cbs 101.672)
by aspergillus niger (cbs 101.672)

chitín odvodený z huby aspergillus niger“.
chitin-glucan derived from aspergillus niger.’;

produkt fermentácie aspidosperma quebracho použitím aspergillus
product of the fermentation of aspidosperma quebracho by aspergillus

táto infekcia je zapríčinená plesňou nazývanou aspergillus.
this infection is caused by a mould called aspergillus.

aspergillus ferment je produkt získaný fermentáciou aspergillus
aspergillus ferment is the product obtained by the fermentation of aspergillus

amyláza es 3.2.1.1 z aspergillus oryzae
amylase ec 3.2.1.1 from aspergillus oryzae

fermentačný produkt aspergillus oryzae nrrl 458: 4 – 5 %
fermentation product of aspergillus oryzae nrrl 458: 4 to 5 %

najčastejšie hlásenými invazívnymi mykotickými infekciami boli pneumocystis a aspergillus.
the most commonly reported invasive fungal infections were pneumocystis and aspergillus.

glukóza oxidáza es 1.1.3.4 z aspergillus niger
glucose oxidase ec 1.1.3.4 from aspergillus niger

niektoré rezistentné izoláty sa zistili vo vtáčej plesni aspergillus fumigatus.
some resistant isolates have been identified from avian aspergillus fumigatus.

3-fytáza produkovaná mikroorganizmom aspergillus niger(cbs 101.672)
3-phytase produced by aspergillus niger (cbs 101.672)

candida alebo aspergillus) u febrilných neutropenických dospelých alebo pediatrických pacientov.
refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses of effective antifungal therapy. • empirical therapy for presumed fungal infections (such as candida or aspergillus) in febrile, neutropaenic adult or paediatric patients.

aspergillus fumigatus aspergillus flavus aspergillus niger aspergillus terreus aspergillus nidulans aspergillus versicolor
aspergillus fumigatus aspergillus flavus aspergillus niger aspergillus terreus aspergillus nidulans aspergillus versicolor